Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-01-02 @ 8:45 AM
Study NCT ID:
NCT04601766
Status:
COMPLETED
Last Update Posted:
2021-06-30
First Post:
2020-10-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Sponsor:
Asieris Pharmaceuticals (AUS) Pty Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-30
Start Date Type:
ACTUAL
Primary Completion Date:
2020-12-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-20
First Submit QC Date:
None
Study First Post Date:
2020-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-06-25
Last Update Post Date:
2021-06-30
Last Update Post Date Type:
ACTUAL